Bitget App
Trade smarter
Open
HomepageSign up
Bitget>
News>
A16z makes first 'DeSci' investment in decentralized biobank platform AminoChain

A16z makes first 'DeSci' investment in decentralized biobank platform AminoChain

The Block2024/09/24 16:00
By: The Block
XOLDTOKEN0.00%
Quick Take Andreessen Horowitz’s first DeSci investment is AminoChain, which has raised $7 million is pre-seed and seed financing. AminoChain is building a “decentralized biobank” and Layer 2 network, which will connect enterprise medical institutions looking to share medical data.

Major venture capital firm Andreessen Horowitz has invested in its first "DeSci" (as in "decentralized science") project — AminoChain, according to a16z General Partner Arriana Simpson on X. A16z led the $5 million seed round announced on Wednesday. 

The project is looking to bring “ownership, transparency, and consent” into the field of medical data collection using blockchain technology. AminoChain is building a “decentralized biobank” and Layer 2 network that will connect enterprise medical institutions looking to share medical data while preserving patient privacy, Simpson said. 

According to AminoChain’s website, medical institutions can install “Amino Node” software and integrate it with its existing tech stack. “While data stays self-custodial on the given institutions' servers, the Node software harmonizes and standardizes the data into a common format, making it interoperable with a network of collaborators,” the startup said. 

“The Node software thereby sources data from all providers and brings credible neutrality to the network; from this basis, developers can source data from a multitude of medical bodies and build any number of patient-centric applications,” AminoChain continued. 

Decentralized science, or DeSci, refers to the use of blockchain to make various aspects of scientific research and collaboration more open, incentivized and community-driven. 

The first application that will be built on AminoChain will be a peer-to-peer marketplace for “bio-samples” called the Specimen Center, which will house an inventory of research samples of human tissue potentially useful for scientific research.

“With Specimen Center, biobanks can now give permission for researchers and collaborators to query their sample collections, and they can equally query for research assets available to them. Between institutions, users can streamline licensing agreements, track sample and data use, and maintain full provenance of biosamples across an interoperable network of biobanks,” the company said. 

AminoChain previously raised $2 million in pre-seed financing, bringing its total raised to date to $7 million.


Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Bitget x BAY Carnival: Grab a share of 4,000,000 BAY!
Bitget Announcement2025/11/03 10:00

Trending news

More
1
Invite friends to copy trade and grab a share of 80,000 USDT! ​
2
KITEUSDT now launched for futures trading and trading bots

Crypto prices

More
Bitcoin
Bitcoin
BTC
$104,602.91
-2.51%
Ethereum
Ethereum
ETH
$3,496.73
-5.51%
Tether USDt
Tether USDt
USDT
$0.9998
+0.00%
XRP
XRP
XRP
$2.27
-5.63%
BNB
BNB
BNB
$952.48
-7.45%
Solana
Solana
SOL
$158.28
-9.92%
USDC
USDC
USDC
$1.0000
+0.02%
TRON
TRON
TRX
$0.2813
-4.16%
Dogecoin
Dogecoin
DOGE
$0.1637
-5.20%
Cardano
Cardano
ADA
$0.5377
-5.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now
Trade smarter